Kadakkal Radhakrishnan

Dr. Kadakkal Radhakrishnan


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2021 in Current Gastroenterology Reports
Verified
Journal Article
Closed access
PDF file
CCCharles B. Chen
Charles B. Chen
BHBilasan Hammo
Bilasan Hammo
JBJessica Clinic Children's Barry
Jessica Clinic Children's Barry
KRKadakkal Radhakrishnan
Kadakkal Radhakrishnan

15 February 2012 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
VUVictor Uko
Victor Uko
STSuraj Thangada
Suraj Thangada
KRKadakkal Radhakrishnan
Kadakkal Radhakrishnan
Disorders of the hepatobiliary system are relatively common extraintestinal manifestations of inflammatory bowel disease (IBD). These disorders are sometimes due to a shared pathogenesis with IBD as seen in primary sclerosing cholangitis (PSC) and small-duct primary sclerosing cholangitis (small-duct PSC). There are also hepatobiliary manifestations such as cholelithiasis and portal vein thrombosis that occur due to the effects of chronic inflammation and the severity of bowel disease. Lastly, medications used in IBD such as sulfasalazine, thiopurines, and methotrexate can adversely affect the liver. It is important to be cognizant of these disorders as some do have serious long-term consequences. The management of these disorders often requires the expertise of multidisciplinary teams to achieve the best outcomes.

6 May 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KDKaela Drzewiecki
Kaela Drzewiecki
JCJungmin Choi
Jungmin Choi
JBJoseph Brancale
Joseph Brancale
MLMichael A. Leney-Greene
Michael A. Leney-Greene
SSSinan Sari
Sinan Sari
SVSílvia Vilarinho
Sílvia Vilarinho
Portal hypertension is a major contributor to decompensation and death from liver disease, a global health problem. Here, we demonstrate homozygous damaging mutations in GIMAP5, a small organellar GTPase, in four families with unexplained portal hypertension. We show that GIMAP5 is expressed in hepatic endothelial cells and that its loss in both humans and mice results in capillarization of liver sinusoidal endothelial cells (LSECs); this effect is also seen when GIMAP5 is selectively deleted in endothelial cells. Single-cell RNA-sequencing analysis in a GIMAP5-deficient mouse model reveals replacement of LSECs with capillarized endothelial cells, a reduction of macrovascular hepatic endothelial cells, and places GIMAP5 upstream of GATA4, a transcription factor required for LSEC specification. Thus, GIMAP5 is a critical regulator of liver endothelial cell homeostasis and, when absent, produces portal hypertension. These findings provide new insight into the pathogenesis of portal hypertension, a major contributor to morbidity and mortality from liver disease.

24 August 2020 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
CCCharles B. Chen
Charles B. Chen
FTFarah Tahboub
Farah Tahboub
TPThomas Plesec
Thomas Plesec
MKMarsha Kay
Marsha Kay
KRKadakkal Radhakrishnan
Kadakkal Radhakrishnan

1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
OAOrhan Atay
Orhan Atay
KRKadakkal Radhakrishnan
Kadakkal Radhakrishnan
JAJanine Arruda
Janine Arruda
RWRobert Wyllie
Robert Wyllie
Severe chest pain in a pediatric ulcerative colitis patient after 5-aminosalicylic acid therapy

31 October 2023 in Gastro Hep Advances
Verified
Journal Article
Open access
DLDarren Liu
Darren Liu
SMSuzanne Patricia MacFarland
Suzanne Patricia MacFarland
LYLamis Yehia
Lamis Yehia
MDMelani M. Duvall
Melani M. Duvall
PMPetar Mamula
Petar Mamula
CECharis Eng
Charis Eng
PTEN hamartoma tumor syndrome (PHTS) confers a high risk of specific cancers and is the most common genetic cause of autism spectrum disorder (ASD). Gastrointestinal (GI) phenotypes in PHTS are poorly characterized in children. Thus, we aimed to characterize the GI and hepatic manifestations in children with PHTS and to investigate genotype-phenotype associations. We performed a retrospective chart review of prospectively accrued children with PHTS at 2 tertiary-care centers. Wilcoxon rank-sum, Chi-squared, and Fisher’s exact tests and Firth’s logistic regression were utilized to explore associations between variables. This series included 80 children with disease-causing PTEN variants. Common GI manifestations included constipation in 41 (51%), feeding issues in 31 (39%), and polyps in 22 (28%) children. The polyps were of mixed histologic types. Eosinophilic gastrointestinal disorders were observed in 5 (6%) children. Crohn’s disease, celiac disease, and protein-losing enteropathy were observed once each. Eosinophilic gastrointestinal disorders were observed exclusively in patients without ASD (P = .052). Nonsense PTEN variants were enriched in those with polyps (P = .029). Missense PTEN variants (OR 2.9, P = .034) and upper GI polyps (OR 4.4, P = .018) were associated with increased odds of constipation. Constipation and feeding issues are common in children with PHTS. Polyps are more prevalent in children with PHTS than previously described and associated with nonsense PTEN variants. Children without ASD represent a distinct patient subset with a predisposition to eosinophilic gastrointestinal disorders and possibly upper GI polyps. Endoscopic evaluation should continue to be performed in symptomatic children with PHTS, with consideration of closer follow-up in those without ASD.